{"slug": "bristol-myers-squibb-expands-nvidia-partnership-to-supercharge-its-ai-drug", "title": "Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory", "summary": "Bristol Myers Squibb is expanding its partnership with Nvidia to boost AI computing power for drug discovery, building on its AI Center of Excellence using Nvidia's DGX SuperPOD infrastructure that has been operational since March 2024. The pharma giant reported a 55% overall cost reduction compared to previous AI systems, signaling a structural shift in R&D spending. The collaboration, hosted through Equinix with integration support from Mark III Systems, focuses on oncology imaging analysis and predictive modeling using clinical data.", "body_md": "# Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory\n\nThe pharma giant is doubling down on Nvidia's AI infrastructure to accelerate drug discovery, and the implications ripple far beyond healthcare\n\nBristol Myers Squibb is expanding its partnership with Nvidia to boost AI computing power for developing new medicines.\n\nThe collaboration centers on what BMS calls its AI Center of Excellence, essentially an “AI factory” built on Nvidia’s DGX SuperPOD infrastructure. It’s been operational since March 2024, and the expansion signals that the initial results were compelling enough to warrant going bigger.\n\n## What the AI factory actually does\n\nThe AI factory runs self-supervised models trained on hundreds of thousands of clinical trial images. Its primary applications sit in oncology imaging analysis and predictive modeling using clinical data.\n\nThe infrastructure is hosted through Equinix, with integration support from Mark III Systems. Greg Meyers, BMS’s EVP and Chief Digital & Technology Officer, has been the key executive driving the initiative.\n\nBMS has reported a 55% overall cost reduction compared to its previous AI systems. For a company that spent billions annually on R&D, shaving more than half off the computing costs for AI workloads is not a rounding error. It’s a structural shift in how research dollars get deployed.\n\n## The bigger picture: Nvidia’s pharma play\n\nEli Lilly has entered a co-innovation deal with Nvidia worth up to $1 billion. When two of the world’s largest pharmaceutical companies are building dedicated AI infrastructure on Nvidia hardware, it stops being a trend and starts looking like a new baseline.\n\n## What this means for investors\n\nThe 55% cost reduction BMS achieved is the kind of efficiency metric that attracts capital. When pharma companies can demonstrate that AI infrastructure pays for itself through lower R&D costs, it creates a flywheel effect.\n\nMajor corporations are channeling billions into traditional AI infrastructure for their most mission-critical applications. The up-to-$1 billion Eli Lilly deal and BMS’s expanding AI factory represent real enterprise spending flowing toward GPU compute.\n\nThe pharmaceutical industry, with its regulatory complexity, data sensitivity requirements, and need for validated computing environments, is unlikely to migrate critical drug discovery workloads to decentralized infrastructure anytime soon.\n\n**Disclosure:** This article was edited by Editorial Team. For more information on how we create and review content, see our\n\n[Editorial Policy](https://cryptobriefing.com/editorial-policy/).", "url": "https://wpnews.pro/news/bristol-myers-squibb-expands-nvidia-partnership-to-supercharge-its-ai-drug", "canonical_source": "https://cryptobriefing.com/bristol-myers-nvidia-ai-factory-expansion/", "published_at": "2026-07-20 15:15:15+00:00", "updated_at": "2026-07-20 15:46:40.929959+00:00", "lang": "en", "topics": ["artificial-intelligence", "ai-infrastructure", "ai-chips", "ai-products"], "entities": ["Bristol Myers Squibb", "Nvidia", "Eli Lilly", "Equinix", "Mark III Systems", "Greg Meyers", "DGX SuperPOD"], "alternates": {"html": "https://wpnews.pro/news/bristol-myers-squibb-expands-nvidia-partnership-to-supercharge-its-ai-drug", "markdown": "https://wpnews.pro/news/bristol-myers-squibb-expands-nvidia-partnership-to-supercharge-its-ai-drug.md", "text": "https://wpnews.pro/news/bristol-myers-squibb-expands-nvidia-partnership-to-supercharge-its-ai-drug.txt", "jsonld": "https://wpnews.pro/news/bristol-myers-squibb-expands-nvidia-partnership-to-supercharge-its-ai-drug.jsonld"}}